Near term catalysts:
'Upcoming readout of Phase 1b/2 rosacea study, start of Phase 2b antimicrobial study,
Phase 1b canine dermatitis data readout and announcement of new pipeline
opportunities' - Exploring other pipeline opportunities for later stage dermatology assets
that are closer to approval and revenue generation
Ann: Investor Presentation, page-2
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $441.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 27.8¢ | $1.907M | 6.651M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 697753 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 154676 | 3 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
-0.010 ( 0.90 %) |
||||
| Open | High | Low | Volume | ||
| 29.3¢ | 29.5¢ | 27.5¢ | 2409493 | ||
| Last updated 15.56pm 09/05/2024 ? | |||||
| BOT (ASX) Chart |